Skip to content

LH · NYSE

Labcorp Holdings (LH) Stock Price & Fundamentals

$580.07+1.76%+$10.04End-of-day price as of Oct 9, 2026

Labcorp Holdings (LH) closed at $580.07 on Oct 9, 2026, up 1.76% from the previous close of $570.03.

Share price, past year

1Y +22.59%

52-week range $473.18 – $601.42. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$580.07
Sep 30, 2026$566.85
Aug 31, 2026$554.38
Jul 31, 2026$571.47
Jun 30, 2026$552.70
May 29, 2026$564.79
Apr 30, 2026$592.35
Mar 31, 2026$587.44
Feb 27, 2026$556.89
Jan 30, 2026$569.12
Dec 31, 2025$529.50
Nov 28, 2025$502.84
Oct 31, 2025$497.48

Key statistics

Market cap
$46.93B
P/E (TTM)
48.0
EPS (TTM)
$12.09
Revenue (TTM)
$14.35B
Net income (TTM)
$1.00B
Shares outstanding
80.9M
Dividend yield
—
52-week range
$473.18 – $601.42

Labcorp Holdings's market cap is $46.93B, based on a share price of $580.07 and 80.9M shares outstanding as of Jun 30, 2026.

Financials

Labcorp Holdings reported revenue of $13.95B for fiscal 2025, up 7.25% from fiscal 2024.

Labcorp Holdings earned net income of $876.50M in fiscal 2025, a net margin of 6.3%.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Labcorp Holdings annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$13.95B+7.3%$876.50M6.3%$10.46$1.21B
FY2024ended Dec 31, 2024$13.01B+7.0%$746.00M5.7%$8.84$1.10B
FY2023ended Dec 31, 2023$12.16B+2.5%$418.00M3.4%$4.77$874.10M
FY2022ended Dec 31, 2022$11.86B−9.7%$1.28B10.8%$13.97$1.53B
FY2021ended Dec 31, 2021$13.14B−6.0%$2.38B18.1%$24.39$2.69B
FY2020ended Dec 31, 2020$13.98B+21.0%$1.56B11.1%$15.88$1.75B
FY2019ended Dec 31, 2019$11.55B+2.0%$823.80M7.1%$8.35$1.04B
FY2018ended Dec 31, 2018$11.33B+10.0%$883.70M7.8%$8.61$925.60M
FY2017ended Dec 31, 2017$10.31B+7.9%$1.23B11.9%$11.81$1.19B
FY2016ended Dec 31, 2016$9.55B—$711.80M7.5%$6.82$918.20M
Labcorp Holdings quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$3.73B$298.70M$3.64
Q1 FY2026ended Mar 31, 2026$3.54B$277.80M$3.35
Q4 FY2025ended Dec 31, 2025$3.52B$164.70M$1.98
Q3 FY2025ended Sep 30, 2025$3.56B$261.10M$3.12
Q2 FY2025ended Jun 30, 2025$3.53B$237.90M$2.84
Q1 FY2025ended Mar 31, 2025$3.35B$212.80M$2.52
Q4 FY2024ended Dec 31, 2024$3.33B$143.40M$1.72
Q3 FY2024ended Sep 30, 2024$3.28B$169.30M$2.00

Company profile

Name
Labcorp Holdings Inc.
Ticker
LH
Exchange
NYSE
Industry (SEC SIC)
Services-Medical Laboratories
Headquarters
358 S Main St, Burlington, NC 27215
Fiscal year ends
December
SEC CIK
0000920148

Recent SEC filings

Frequently asked questions

What is Labcorp Holdings's stock price?

Labcorp Holdings (LH) closed at $580.07 on Oct 9, 2026, up 1.76% from the previous close of $570.03.

What is Labcorp Holdings's market cap?

Labcorp Holdings's market cap is $46.93B, based on a share price of $580.07 and 80.9M shares outstanding as of Jun 30, 2026.

How much revenue does Labcorp Holdings make?

Labcorp Holdings reported revenue of $13.95B for fiscal 2025, up 7.25% from fiscal 2024.

What is LH's P/E ratio?

Labcorp Holdings's price-to-earnings ratio is 48.0, based on trailing twelve-month diluted EPS of $12.09.

Does Labcorp Holdings pay a dividend?

Labcorp Holdings's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Labcorp Holdings Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures